Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) to model arrhythmogenic diseases

被引：1
|
作者：
Pourrier, Marc [1 ]
Dou, Ying [1 ]
Luerman, Greg [2 ]
Fedida, David [1 ,3 ]
机构：
[1] IonsGate Preclin Serv Inc, Vancouver, BC, Canada
[2] Axiogenesis AG, Cologne, Germany
[3] Univ British Columbia, Vancouver, BC, Canada
来源：
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS | 2018年 / 93卷
关键词：
D O I：
10.1016/j.vascn.2018.01.404
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
030
引用
收藏
页码：118 / 118
页数：1
相关论文
共 50 条
  • [1] The Emergence of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) as a Platform to Model Arrhythmogenic Diseases
    Pourrier, Marc
    Fedida, David
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (02)
  • [2] Spontaneous Ca2+ Oscillations in Beating Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (HIPSC-CM) and Rat Neonatal Cardiomyocytes (RN-CM)
    Zhang, Xiao-Hua
    Stone, Susannah L.
    Fatima, Azra
    Hescheler, Juergen
    Saric, Tomo
    Morad, Martin
    BIOPHYSICAL JOURNAL, 2012, 102 (03) : 506A - 506A
  • [3] Generation and characterization of human induced pluripotent stem cells (hiPSC) and hiPSC-derived cardiomyocytes (hiPSC-CM) lacking microRNA-378a
    Martyniak, A.
    Coste, S.
    Motais, B.
    Stepniewski, J.
    Dulak, J.
    FEBS OPEN BIO, 2019, 9 : 242 - 242
  • [4] Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (hiPSC-CM) Showed Similar Potency as Human Mesenchymal Stem Cells (hMSC) in Treating Myocardial Infarction
    Khan, Mahmood
    Citro, Lucas
    Kuppusamy, Periannan
    Angelos, Mark C.
    CIRCULATION, 2013, 128 (22)
  • [5] Human myofibroblasts increase the arrhythmogenic potential of human induced pluripotent stem cell-derived cardiomyocytes
    Johnson, Robert D.
    Lei, Ming
    Mcvey, John H.
    Camelliti, Patrizia
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2023, 80 (09)
  • [6] Investigation on arrhythmogenic potential of phenanthrene using human induced pluripotent stem cell-derived cardiomyocytes
    Kim, Min Woo
    Lee, Seul-Gi
    Kim, Jin
    Jeong, Kyu Sik
    Lee, Yun Hyeong
    Lee, Suemin
    Park, Jeong Hwan
    Jeong, Youngin
    Lee, Myeonghee
    Kim, Yoonseo
    Chung, Hyung Min
    Kim, C-Yoon
    MOLECULAR & CELLULAR TOXICOLOGY, 2024,
  • [7] HUMAN MYOFIBROBLASTS INCREASE THE ARRHYTHMOGENIC POTENTIAL OF HUMAN-INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES
    Johnson, R. D.
    Mcvey, J. H.
    Camelliti, P.
    CARDIOVASCULAR DRUGS AND THERAPY, 2020, 34 (02) : 280 - 281
  • [8] The arrhythmogenic potential of nerve agents and a cardiac safety profile of antidotes - A proof-of-concept study using human induced pluripotent stem cells derived cardiomyocytes (hiPSC-CM)
    Amend, Niko
    Thiermann, Horst
    Worek, Franz
    Wille, Timo
    TOXICOLOGY LETTERS, 2019, 308 : 1 - 6
  • [9] microRNAs in human-induced pluripotent stemcell-derived cardiomyocytes (hiPSC-CM) as predictive biomarkers of structural cardiotoxicity
    Cherubin, Martina
    Gryshkova, Vitalina
    Valentin, Jean-Pierre
    Guns, Pieter-Jan
    Alaerts, Maaike
    Delaunois, Annie
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2023, 123
  • [10] Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs)
    Narkar, Akshay
    Willard, James M.
    Blinova, Ksenia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (06)
12345